The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $100.29

Today's change-0.24 -0.24%
Updated November 26 10:50 AM EST. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $100.29

Today's change-0.24 -0.24%
Updated November 26 10:50 AM EST. Delayed by at least 15 minutes.

Laboratory Corporation of America Holdings down (U.S.)$0.24

Laboratory Corporation of America Holdings is lower today, dropping (U.S.)$0.24 or 0.24% to (U.S.)$100.29. Shares have lost 0.65% over the last five days, but have gained 9.76% over the last year to date. This security has underperformed the S&P 500 by 19.31% during the last year.

Key company metrics

  • Open(U.S.) $100.43
  • Previous close(U.S.) $100.53
  • High(U.S.) $100.87
  • Low(U.S.) $100.17
  • Bid / Ask(U.S.) $100.28 / (U.S.) $100.31
  • YTD % change+9.76%
  • Volume287,540
  • Average volume (10-day)1,355,626
  • Average volume (1-month)1,723,254
  • Average volume (3-month)964,176
  • 52-week range(U.S.) $87.01 to (U.S.) $109.47
  • Beta0.66
  • Trailing P/E16.82×
  • P/E 1 year forward14.83×
  • Forward PEG2.98×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.96
Updated November 26 10:50 AM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.75%

Based on its net profit margin of 8.75%, Laboratory Corporation of America Holdings is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.32%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,5521,5161,4311,437
Total other revenue--------
Total revenue1,5521,5161,4311,437
Gross profit571569517526
Total cost of revenue981948914911
Total operating expense1,3101,2701,2271,222
Selling / general / administrative306298285286
Research & development--------
Depreciation / amortization18222121
Interest expense (income), net operating--------
Unusual expense (income)6284
Other operating expenses, total--------
Operating income241247203215
Interest income (expense), net non-operating-26-26-26-24
Gain (loss) on sale of assets--------
Other--------
Income before tax219233188194
Income after tax138142114127
Income tax, total82917468
Net income137141113126
Total adjustments to net income--------
Net income before extra. items137141113126
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items137141113126
Inc. avail. to common incl. extra. items137141113126
Diluted net income137141113126
Dilution adjustment--000
Diluted weighted average shares87868788
Diluted EPS excluding extraordinary itemsvalue per share1.591.641.311.43
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.631.651.361.46